Comparison of Branded and Generic Imatinib Plasma Concentrations in Patients With Chronic Myelogenous Leukemia: Unicentric Study. [electronic resource]
Producer: 20171103Description: 472-6 p. digitalISSN:- 2152-2669
- Adult
- Aged
- Antineoplastic Agents -- pharmacokinetics
- Drug Costs
- Drug Monitoring
- Drugs, Generic
- Female
- Humans
- Imatinib Mesylate -- pharmacokinetics
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Medication Adherence
- Middle Aged
- Protein Kinase Inhibitors -- pharmacokinetics
- Therapeutic Equivalency
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.